Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AE.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AE.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AE.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.201EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.201ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.201ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.201EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.201EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.201ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.221EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.221ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.221ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.221EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.221EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.221ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.221ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.410EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.410EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.410ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.410ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.410EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.410EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.410ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.410ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.357EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.357EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.357ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.357ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.357EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-19663.3China
B.1.357EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.357ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.357ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.318EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.318ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.318ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.318EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.318EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.318ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.318ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.557EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.557EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.557ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.557ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used